Millions of fentanyl patches recalled

It's a new blow for the controversial painkiller fentanyl. Johnson & Johnson and Sandoz are recalling defective fentanyl patches that could cause patients or caregivers to overdose. The recall follows a December FDA warning that misuse can cause overdose, and another in July 2005 that instructed patients to follow package instructions strictly to avoid overdosing.

Some of the patches may have a cut in the drug reservoir that could leak potent opioid gel. Exposure to it can lead to respiratory depression and overdose, J&J said in a statement. About 32 million of the patches will be recalled. The FDA says it's investigating.

- see J&J's release about the recall
- read the AP report
- check out more from The Wall Street Journal

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.